A study on the effect of memantine for psychological symptoms and cerebral blood flow of patients with Alzheimer's disease.

A study on the effect of memantine for psychological symptoms and cerebral blood flow of patients with Alzheimer's disease. - Memantine study on Alzheimer's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010794

Enrollment

Registered

2013-05-25

Start date

2013-06-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer&#39

Interventions

memantine memantine and cholinesterase inhibitor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Enrollment at Jikei University Katsushika Medical Center 2)Obtained informed consent 3)Age 65 and more

Exclusion criteria

Exclusion criteria: History of severe kidney disease History of renal tubular acidosis or severe urinary tract infection History of severe liver disease History of epilepsy Other difficulties judged by the physician in charge

Design outcomes

Primary

Measure	Time frame
Cognitive function,MRI,SPECT	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

A study on the effect of memantine for psychological symptoms and cerebral blood flow of patients with Alzheimer&#39;s disease.